Notch1 loss of heterozygosity causes vascular tumors and lethal hemorrhage in mice
Open accessThe DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
The role of the Notch signaling pathway in tumor development is complex, with Notch1 functioning either as an oncogene or as a tumor suppressor in a context-dependent manner. To further define the role of Notch1 in tumor development, we systematically surveyed for tumor suppressor activity of Notch1 in vivo. We combined the previously described Notch1 intramembrane proteolysis-Cre (Nip1::Cre) allele with a floxed Notch1 allele to create a mouse model for sporadic, low-frequency loss of Notch1 heterozygosity. Through this approach, we determined the cell types most affected by Notch1 loss. We report that the loss of Notch1 caused widespread vascular tumors and organism lethality secondary to massive hemorrhage. These findings reflected a cell-autonomous role for Notch1 in suppressing neoplasia in the vascular system and provide a model by which to explore the mechanism of neoplastic transformation of endothelial cells. Importantly, these results raise concerns regarding the safety of chronic application of drugs targeting the Notch pathway, specifically those targeting Notch1, because of mechanism-based toxicity in the endothelium. Our strategy also can be broadly applied to induce sporadic in vivo loss of heterozygosity of any conditional alleles in progenitors that experience Notch1 activation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Moreover, a chronic blockade of Notch signaling leads to vascular tumors of the liver, skin, ovary, testes and colon in mice [140, 141].”
From Tumor microenvironment signaling and therapeutics in cancer progression (2023) · cites this paper as [140]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Generalized lacZ expression with the ROSA26 Cre reporter strain
Soriano, P. (1999) · Nature Genetics · doi:10.1038/5007 · Cited by 4,859 · cited 6×
“We have previously reported that when N1::Cre is combined with the RosaLacZ reporter, the excision of the floxed stop cassette by ligand-dependent release of Cre indelibly labels cells that have experienced Notch1 activation.”
BackgroundInfluentialThe Canonical Notch Signaling Pathway: Unfolding the Activation Mechanism
Kopan, R., & Ilagan, M. X. G. (2009) · Cell · doi:10.1016/j.cell.2009.03.045 · Cited by 3,643 · cited 1×
“Introduction The Notch pathway is an evolutionarily conserved signaling mechanism that plays essential roles both during development and in the maintenance of adult tissue homeostasis in metazoan (1).”
BackgroundSelf-citationCre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus
Srinivas, S., Watanabe, T., Lin, C.-S., William, C. M., Tanabe, Y., Jessell, T. M., & Costantini, F. (2001) · BMC Developmental Biology · doi:10.1186/1471-213x-1-4 · Cited by 3,121 · cited 8×
“CD105+CD45– proliferating liver ECs from N1::Crelo/flRosaEYFP/LacZ and N1::Crelo/+RosaEYFP/LacZ mice were collected (Figure 6A), and the DNA was purified and subjected to PCR amplification in order to detect the 3 Notch1 alleles: a normal promoter in the N1::Crelo allele, a floxed promoter in N1fl allele, and a rearra…”
BackgroundInfluentialActivating Mutations of NOTCH1 in Human T Cell Acute Lymphoblastic Leukemia
Weng, A. P., Ferrando, A. A., Lee, W., Morris, J. P., Silverman, L. B., Sanchez-Irizarry, C., Blacklow, S. C., Look, A. T., & Aster, J. C. (2004) · Science · doi:10.1126/science.1102160 · Cited by 2,715 · cited 2×
“Jeannet R, et al. Oncogenic activation of the Notch1 gene by deletion of its promoter in Ikaros-deficient T-ALL [published online ahead of print September 9, 2010].”
Backgroundvan Es, J. H., van Gijn, M. E., Riccio, O., van den Born, M., Vooijs, M., Begthel, H., Cozijnsen, M., Robine, S., Winton, D. J., Radtke, F., et al. (2005) · Nature · doi:10.1038/nature03659 · Cited by 1,543 · cited 1×
“Considering that Notch1 is continuously required in multiple tissues during development and in the adult (33), especially in the gut (7, 34) and mammary gland (35) stem cell populations, a NIP::Cre allele coupled with floxed alleles of tumor suppressors offers a better model to mimic LOH disease development in human p…”
BackgroundNotch signaling is essential for vascular morphogenesis in mice
Krebs, L. T., Xue, Y., Norton, C. R., Shutter, J. R., Maguire, M., Sundberg, J. P., Gallahan, D., Closson, V., Kitajewski, J., Callahan, R., et al. (2000) · Genes & Development · doi:10.1101/gad.14.11.1343 · Cited by 1,060 · cited 1×
“Concomitant loss of signals from other Notch receptors, such as Notch4 in ECs (38) and Notch2/3 in pericytes (39–41), may have accelerated the tumor formation in their model (37).”
BackgroundBlockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis
Noguera-Troise, I., Daly, C., Papadopoulos, N. J., Coetzee, S., Boland, P., Gale, N. W., Chieh Lin, H., Yancopoulos, G. D., & Thurston, G. (2006) · Nature · doi:10.1038/nature05355 · Cited by 1,032 · cited 4×
“The Notch pathway has emerged as a target to block angiogenesis in solid tumors (9, 10, 36) and eliminate tumor-initiating cells (13), either by the administration of anti-Dll4 antibody Figure 5 Characterization of vascular tumor cells.”
BackgroundResultInfluentialInhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis
Ridgway, J., Zhang, G., Wu, Y., Stawicki, S., Liang, W.-C., Chanthery, Y., Kowalski, J., Watts, R. J., Callahan, C., Kasman, I., et al. (2006) · Nature · doi:10.1038/nature05313 · Cited by 986 · cited 4×
“The Notch pathway has emerged as a target to block angiogenesis in solid tumors (9, 10, 36) and eliminate tumor-initiating cells (13), either by the administration of anti-Dll4 antibody Figure 5 Characterization of vascular tumor cells.”
BackgroundResultInfluentialNotch1 functions as a tumor suppressor in mouse skin
Nicolas, M., Wolfer, A., Raj, K., Kummer, J. A., Mill, P., van Noort, M., Hui, C.-C., Clevers, H., Dotto, G. P., & Radtke, F. (2003) · Nature Genetics · doi:10.1038/ng1099 · Cited by 971 · cited 1×
“In contrast to gain-offunction mutations in Notch1 and their oncogenic role in T-ALL (3, 4), and perhaps in solid tumors, Notch1 loss-of-function mutations have only been implicated in a limited number of tumors, such as skin (2), where Notch1 loss promotes tumor formation non–cell-autonomously by creating a wound-lik…”
BackgroundNotch1 is required for the coordinate segmentation of somites
Conlon, R. A., Reaume, A. G., & Rossant, J. (1995) · Development · doi:10.1242/dev.121.5.1533 · Cited by 852
Cited by
Items 101–121 of 121
Tirrò, E., Martorana, F., Micale, G., Inzerilli, N., Carciotto, R., Romano, C., Longhitano, C., Motta, G., Lanzafame, K., Stella, S., et al. (2022) · Pathology - Research and Practice · doi:10.1016/j.prp.2022.153820 · Cited by 7
Tissue-scale mechanics controls differentiation strategy and dynamics of epithelial multilayeringPreprint
Villeneuve, C., Azote, S., Albu, M., Rübsam, M., Biggs, L. C., Vinzens, S., Kruse, K., Prakash, A., Zentis, P., Lawson-Keister, E., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.08.704529 · Cited by 8
“Leiden clustering revealed that cell states were clustered separately according to their developmental stage, indicating that key cell states (basal and suprabasal cells) underwent substantial transcriptional changes in transcriptomes while progressing through development (Fig.”
Heinzelmann, K., Fysikopoulos, A., Jaquin, T. J., Peper-Gabriel, J. K., Hansbauer, E.-M., Grüner, S., Prassler, J., Wurzenberger, C., Kennedy, J. G. C., Snead, J. Y., et al. (2024) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00059.2024 · Cited by 6
Interrogating Cellular Communication in Cancer with Genetically Encoded Imaging Reporters
Gammon, S. T., Liu, T. W. B., & Piwnica-Worms, D. R. (2020) · Radiology Imaging Cancer · doi:10.1148/rycan.2020190053 · Cited by 5
Self-citationSolano, A. F., Preuße, K., Cain, B., Hotz, R., Gavini, P., Yuan, Z., Bowen, B., Maco, G., Neal, H., Gagliani, E. K., et al. (2025) · Journal of Clinical Investigation · doi:10.1172/jci187532 · Cited by 2
“In addition, the increase in hemorrhages in these embryos suggests vascular integrity is compromised, similar to that seen with anti-DLL4 antibodies (47) or N1 loss-of-heterozygosity models (48).”
Self-citationPreuße, K., Cochran, K., Dai, Q., & Kopan, R. (2025) · PLoS ONE · doi:10.1371/journal.pone.0311353 · Cited by 3
Self-citationMultiscale in vivo imaging of tumor evolution using a germline conditional triple-reporter mouse
Iraolagoitia, X. L. R., Alyamani, A., May, S., Stevenson, D., Mackintosh, A., McGarry, L., Anand, J., Soloviev, D., Brown, G. D., Nixon, C., et al. (2026) · Nature Biotechnology · doi:10.1038/s41587-026-03184-3 · Cited by 1
“Numerous reporter strains are widely used and are available for multiple modalities, working with bioluminescence 7,8 , fluorescence 7,9 or radionuclide imaging 10 , but none of these covers the full range of spatial scales and tissue depths required for multiscale imaging.”
Stapor, P. C., Bock, K. D., & Carmeliet, P. (2015) · Springer eBooks · doi:10.1007/978-3-642-37078-6_10 · Cited by 2
Beyond VEGF: The NOTCH and ALK1 Signaling Pathways as Tumor Angiogenesis Targets
Nolan-Stevaux, O., & Toni, H. (2012) · InTech eBooks · doi:10.5772/26834 · Cited by 1
“The liver in particular, was the organ most affected by NOTCH1 activated loss and had evidence of hemangiomas and proliferation specifically associated with NOTCH1 loss (Liu et al., 2011).”
BackgroundStapor, P. C., Bock, K. D., & Carmeliet, P. (2014) · Springer eBooks · doi:10.1007/978-3-642-37393-0_10-1 · Cited by 1
Molecular Signaling Pathways in Infantile Hemangiomas
Phung, T. L. (2013)
Walter, L. (2022) · Digital Archive @ GSU · doi:10.57709/11893597
Sinicropi-Yao, S. L., Koenig, M. J., & Carbone, D. P. (2018) · Springer eBooks · doi:10.1007/978-1-4939-8859-4_10
Rothweiler, S., & Semela, D. (2015) · Wiley eBooks · doi:10.1002/9781118663387.ch20
Novel Treatment Strategies for Brain metastases of Breast Cancer
Mohammad, A. S. (2017) · The Research Repository @ WVU (West Virginia University) · doi:10.33915/etd.6242
The Differential Expression of EGFL7 Transcripts during Angiogenesis in Human Fibrosarcoma
Baktash, N. (2012) · Scholarship@Western (Western University)
Precision medicine in oral cancer
Sastri, K. T., Sridhar, S. B., Chalasani, S. H., Ramesh, M., Murugan, M. D., Pal, N., Syed, J. M., & Srivastava, S. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-31592-3.00013-3
PRODUCTION OF WHOLE NECROTIC TUMOR CELL LYSATES FROM COLORECTAL CANCER
Benadla, M. Y. M. I. E. (2024) · Dépôt Institutionnel de lUniversité de Tlemcen
Bays, J., Teo, J. L., Rodriguez, F. S., Farrell, A. M., Stoddard, A. E., Koh, E., Hla, T., & Chen, C. S. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.20.726610
“Lastly, it is noted that both S1P and Notch signaling also govern broader aspects of endothelial biology—including maintenance of quiescence, coordination of tip and stalk cells during angiogenic sprouting, and protection against inflammation and atherosclerosis 11, 13, 14, 17, 44 .”
Novel Role of ErbB-2 in Inhibition of Jagged-1-Mediated Trans-Activation of Notch in Breast Cancer
Pandya, K. (2013) · Loyola eCommons (Loyola University of Chicago)
Metadata
- Authors
- Liu, Z., Turkoz, A., Jackson, E. N., Corbo, J. C., Engelbach, J. A., Garbow, J. R., Piwnica-Worms, D. R., & Kopan, R.
- Affiliations
- Washington University in St. Louis (US)
- Corresponding author
- Kopan, Raphael
- Venue
- Journal of Clinical Investigation
- Published
- 2011-02-01
- Volume
- 121
- Issue
- 2
- Pages
- 800-808
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC3026721
- OpenAlex
- W2145967409
- Cited by
- 119
- References
- 45
- Citations by year
- 2026: 4 · 2025: 2 · 2024: 2 · 2023: 1 · 2022: 4 · 2021: 2 · 2020: 4 · 2019: 2 · 2018: 8 · 2017: 8 · 2016: 6 · 2015: 12 · 2014: 15 · 2013: 18 · 2012: 10
- FWCI
- 8.32
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Digital Commons@Becker (Washington University School of Medicine) (submittedVersion)
- Funders
- Alvin J. Siteman Cancer Center
- National Institutes of Health
- National Eye Institute (R01EY018826)
- National Cancer Institute (P30 CA 91842, U24CA083060, U24 CA83060, P50CA094056, P30CA091842)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK066408)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- Notch1, loss of heterozygosity, tumor suppressor function, vascular tumors, hemorrhage, Notch signaling, conditional alleles, drug safety, mouse model
- MeSH terms
- Animals, Hemorrhage, Humans, Magnetic Resonance Imaging, Recombinant Fusion Proteins, Signal Transduction, Survival Rate, Disease Progression, Vascular Neoplasms, Loss of Heterozygosity, Mice, Receptor, Notch1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.